About Inspire
Inspire Pharmaceuticals, Inc. (Inspire) biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The Company’s portfolio of products and product candidates include Elestat, Restasis, AzaSite, Prolacria and Denufosol tetrasodium. The advanced compounds – more... in its clinical pipeline are Prolacria for dry eye and denufosol tetrasodium for cystic fibrosis, which are both in Phase III development and AzaSite for blepharitis, which is beginning Phase II development.
(Source: 10-K) – less – More from ZoomInfo »
